Antiphospholipid antibodies (aPL) are associated with an increased incidenc
e of fetal loss, but the pathophysiology remains unclear. One mechanism may
involve the binding of aPL directly to the placenta where they may initiat
e placental thrombosis and infarction. We have developed an immunofluoresce
nt technique to detect human aPL binding to human placenta. Endogenous immu
noglobulins were eluted by extensive washing and residual staining was prev
ented by incorporating multiple blocking steps. APL were affinity purified
on both cardiolipin and phosphatidylserine liposomes from the sera of six p
atients with aPL (five antiphospholipid syndrome (,APS) patients and one po
st bone marrow transplant patient). Heterogeneous binding to normal term pl
acenta, involving either the trophoblast microvillous surface, stromal and
perivascular regions was demonstrated by affinity purified aPL from five of
six patients. Preliminary sodium dodecyl sulphate-polyacrylamide gel elect
rophoresis (SDS-PAGE) and western blotting studies have demonstrated that a
PL bind a number of placental proteins. beta(2)GPI was not the predominant
protein bound by aPL using this technique. This study provides further evid
ence for the involvement of aPL in mediating placental damage.